|
000
| 02690cam 2200361zi 4500 |
|---|
| 001 | 9.926953 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20230906085349 |
|---|
| 006 | m o d f |
|---|
| 007 | cr cn||||||||| |
|---|
| 008 | 230906e202302##oncad o f000 0 eng d |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aHP5-163/2023E-PDF |
|---|
| 245 | 00|aEvaluation of the Public Health Agency of Canada’s Blood Safety Contribution Program 2017-18 to 2021-22 / |cprepared by the Office of Audit and Evaluation, Health Canada and the Public Health Agency of Canada. |
|---|
| 246 | 17|aEvaluation of the Blood Safety Contribution Program - September 2022 |
|---|
| 264 | 1|a[Ottawa] : |bPublic Health Agency of Canada = Agence de la santé publique du Canada : |bHealth Canada = Santé Canada, |cFebruary 2023. |
|---|
| 300 | |a1 online resource (vi, 13 pages) : |billustrations, graphs |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aCover title. |
|---|
| 500 | |aIssued also in French under title: Évaluation du Programme de contributions pour la sûreté du sang de l'Agence de la santé publique du Canada de 2017-2018 à 2021-2022. |
|---|
| 520 | |a"This report presents findings from the evaluation of the Blood Safety Contribution Program (BSCP) for the period of 2017-18 to 2021-22. The purpose of the evaluation was to assess the impact, usefulness, and relevance of the information generated from three surveillance systems: the Transfusion Transmitted Injuries Surveillance (TTISS), the Transfusion Errors Surveillance System (TESS), and the Cells, Tissues and Organs Surveillance System (CTOSS). This evaluation did not assess activities undertaken by the provinces and territories, nor their participation in the BSCP"--Executive summary, page ii. |
|---|
| 610 | 20|aPublic Health Agency of Canada|xEvaluation. |
|---|
| 650 | 0|aBlood|xCollection and preservation|zCanada|xEvaluation. |
|---|
| 650 | 0|aBlood|xTransfusion|zCanada|xEvaluation. |
|---|
| 710 | 2 |aPublic Health Agency of Canada. |bOffice of Audit and Evaluation, |eissuing body. |
|---|
| 710 | 1 |aCanada. |bHealth Canada. |bOffice of Audit and Evaluation, |eissuing body. |
|---|
| 775 | 08|tÉvaluation du Programme de contributions pour la sûreté du sang de l'Agence de la santé publique du Canada de 2017-2018 à 2021-2022 / |w(CaOODSP)9.926966 |
|---|
| 856 | 40|qPDF|s734 KB|uhttps://publications.gc.ca/collections/collection_2023/aspc-phac/HP5-163-2023-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/public-health/corporate/transparency/corporate-management-reporting/evaluation/blood-safety-contribution-program-2017-2018-2021-2022.html |
|---|